The CIHR Canadian HIV Trials Network (CTN) is a partnership of clinical investigators, physicians, nurses, people living with HIV, pharmaceutical manufacturers and others that facilitate HIV clinical trials and research projects. CTN will be supporting the EPIC4 study by offering data management and analysis services. The CTN main office is based in Vancouver, British Columbia.
National HIV and Retrovirology Laboratory (NHRL) of the Public Health Agency of Canada is located in Winnipeg, Manitoba. It will provide services for measurement of HIV‐1 reservoirs.
The National Institute of Allergy and Infectious Diseases (NIAID) from the National Institutes of Health is located in Bethesda, Maryland, USA. Under the supervision of Dr. Tae Wook Chun, the NIAID will provide key expertise regarding measurement of HIV‐1 reservoirs.
The mission of the Canadian HIV Cure Enterprise (CanCURE) is to study mechanisms governing HIV persistence in order to develop effective therapeutic strategies aiming towards a functional cure for HIV/AIDS. CanCURE is also funded through the Canadian Initiative for HIV Cure Research, a partnership between the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for AIDS Research (CANFAR) and the International AIDS Society (IAS).